Showing results (331-340 of 527) with videos related to
Sort By:
Pageof 53
ESMO Open|May 20, 2020
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcomeIlaria Trestini, Isabella Sperduti, Marco Sposito, et al.Virchows Archiv : an International Journal of Pathology|February 2, 2018
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigmGiuseppe Pelosi, Fabrizio Bianchi, Elisa Dama, et al.Expert Opinion on Drug Discovery|October 4, 2013
Advances towards the design and development of personalized non-small-cell lung cancer drug therapySabrina Vari, Sara Pilotto, Marcello Maugeri-Saccà, et al.Journal of Thoracic Disease|August 14, 2025
Short-term results of salvage surgery after immune and target therapies in non-small cell lung cancerMarco Chiappetta, Carolina Sassorossi, Filippo Lococo, et al.Pathologica|October 8, 2024
A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockadeAlessio Cortellini, Claudia Zampacorta, Michele De Tursi, et al.Heliyon|December 17, 2024
Simultaneous care provision to patients with small cell lung cancer in Lazio region: Practical recommendations of a multidisciplinary groupSabrina Mariotti, Gabriele Minuti, Lorenza Landi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung CancerMaurice Pérol, Benjamin J Solomon, Koichi Goto, et al.Plos One|September 16, 2009
Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour targetStefania Crispi, Raffaele A Calogero, Mario Santini, et al.Anticancer Research|February 27, 2022
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?Chiara Ciccarese, Roberto Iacovelli, Sebastiano Buti, et al.Cancers|July 31, 2019
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?Ernesto Rossi, Giovanni Schinzari, Ilaria Grazia Zizzari, et al.Pageof 53